Profile data is unavailable for this security.
About the company
Jacobio Pharmaceuticals Group Co Ltd is an investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly operates its businesses in China market.
- Revenue in HKD (TTM)228.07m
- Net income in HKD-51.70m
- Incorporated2018
- Employees211.00
- LocationJacobio Pharmaceuticals Group Co LtdBuilding F2, No. 88Kechuang 6th Street, Beijing EconomicTechnological Development AreaBEIJING ChinaCHN
- Phone+86 1 056315466
- Fax+86 1 056315314
- Websitehttps://www.jacobiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.61bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.64m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.70 | -0.8203 | -0.8203 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,458.50 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| Hua Medicine | 419.81m | 1.22bn | 3.21bn | 285.00 | 2.48 | 2.49 | 2.55 | 7.65 | 1.23 | 1.23 | 0.4253 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,498,850.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.22m | 3.25bn | 604.00 | 370.46 | 3.92 | 35.51 | 2.69 | 0.0113 | 0.0113 | 1.67 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,977,613.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.73bn | 520.00 | -- | 2.24 | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.80bn | 54.00 | -- | 3.62 | -- | -- | -- | -- | -- | 9.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 362.84m | -217.22m | 4.64bn | 337.00 | -- | 17.88 | -- | 12.77 | -0.978 | -0.978 | 1.63 | 1.15 | 0.2903 | 4.05 | 9.14 | 1,070,314.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 228.07m | -51.70m | 4.72bn | 211.00 | -- | 4.82 | -- | 20.70 | -0.0668 | -0.0668 | 0.2948 | 1.25 | 0.1547 | -- | 7.97 | 887,438.90 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| TYK Medicines Inc | 121.19k | -317.21m | 4.86bn | 163.00 | -- | 11.74 | -- | 40,143.25 | -0.8554 | -0.8554 | 0.0003 | 1.09 | 0.0002 | -- | -- | 792.07 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
| Laekna Inc | 0.00 | -272.08m | 5.56bn | 84.00 | -- | 6.29 | -- | -- | -0.7398 | -0.7398 | 0.00 | 1.98 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -34.25 | -- | -- | -- | -- | -- | -- | -- | 0.1383 | -- | -- | -- | 31.05 | -- | -- | -- |
| Edding Genor Group Holdings Ltd | 253.70m | 22.82m | 6.09bn | 17.00 | 67.63 | 1.28 | 175.08 | 24.00 | 0.0450 | 0.0450 | 0.4885 | 2.37 | 0.1724 | -- | 5.21 | 10,571,020.00 | 1.46 | -48.63 | 1.72 | -55.19 | 99.56 | 97.88 | 8.45 | -2,303.07 | -- | -- | 0.0007 | -- | -- | 73.71 | 92.40 | -- | -43.79 | -- |
| MiRXES Holding Co Ltd | -100.00bn | -100.00bn | 6.59bn | 347.00 | -- | 7.40 | -- | -- | -- | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.83 | -- | 0.1682 | -- | -16.14 | -- | -33.37 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Jacobio Pharmaceuticals Group Co Ltd's reporting currency: Hong Kong Dollar HKD
6.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hillhouse Investment Management Ltd. (Hong Kong)as of 23 May 2025 | 39.34m | 4.97% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 4.36m | 0.55% |
| First Trust Advisors LPas of 09 Jan 2026 | 1.61m | 0.20% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 1.49m | 0.19% |
| China Asset Management Co., Ltd.as of 28 Nov 2025 | 949.80k | 0.12% |
| Allianz Global Investors GmbHas of 30 Sep 2025 | 947.70k | 0.12% |
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2025 | 840.60k | 0.11% |
| Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 2025 | 507.88k | 0.06% |
| BlackRock Fund Advisorsas of 08 Jan 2026 | 316.20k | 0.04% |
| TIAA-CREF Investment Management LLCas of 31 Dec 2025 | 286.80k | 0.04% |
More ▼
Data from 30 Jun 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
